Augmented Momentary Personal Ecological Risk Evaluation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-30
SponsorUniversity of Washington
About this trial
The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management.
The main study aims are:
* To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool.
Young adult participants receiving care for active suicidal ideation will
* Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.
Eligibility criteria
Qualifiers
Young adults (age 16-30 years)
Receiving care at University of Washington Primary Care for suicidal ideation as determined by Electronic Health Record problem list or PHQ-9 suicide risk item >0 in previous year and/or recent (past year) history of suicide attempt and/or active suicidal ideation.
Ability to consent to participate
Disqualifiers
Age <16 or >30,
Non-English speaking
No smart phone access
Any clinical medical/psychiatric condition, severity of that condition, or life situation that would compromise safe and voluntary study participation.
Trial design
Treatments tested in this trial
- AMPERE EMA app
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Washington
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov